Min Implants Max Outcomes Clinical Trial
MIMOCT
Minimize Implants Maximize Outcomes (MIMO) Clinical Trial
1 other identifier
interventional
200
2 countries
14
Brief Summary
Objectives Primary objective: Determine if there is a clinically significant difference in percent Cobb curve correction in a low- vs. high-implant density cohort through a prospective randomized controlled trial. Design and Outcomes Randomized clinical trial of equivalence to test the efficacy and safety of low vs. high implant density instrumentation for spine deformity surgery in AIS patients with Lenke IA curve patterns. Interventions and Duration Intervention: low-implant density group or high-implant density group. Duration: 2 years. Sample Size and Population Target population: 10 to 17 years old with AIS who will undergo instrumented spinal fusion. Sample size needed (power = 90%) is 174 subjects with 87 in each group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2013
CompletedFirst Posted
Study publicly available on registry
February 15, 2013
CompletedStudy Start
First participant enrolled
April 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedAugust 3, 2022
August 1, 2022
6.1 years
January 22, 2013
August 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Cobb Angle
Radiographic, surgical, and patient-reported data will be gathered and analyzed to observe changes between time points. All radiographs will be taken with 3D analysis capability, either with a calibration belt using standard radiograph techniques or with an EOS imaging system. This will allow for additional detailed correction measures, such as change in spinal rotation (orientation of the planes of maximum curvature) and detailed coronal, sagittal and transverse plane measures. Bending films will be taken according to institutional protocol. The SRS-30, SAQ, and EQ5D will be collected at all clinical visits. Study questions will be aligned as much as possible with other prospective scoliosis protocols so as to minimize patient and surgeon response burden. The study protocol requires no additional visits or radiographs beyond standard of care.
pre-surgery ranging 1 year to 1 month and peri surgery at about 3-months, 1-year, and 2-year postoperative
Secondary Outcomes (3)
Blood Loss
During surgery, 1 time occurence
Operative Time
1 time measurement, occurs at surgery
3D parameter correction
collected during surgical procedure
Study Arms (2)
Maximum Number of Screws
ACTIVE COMPARATOROnce enrolled and consented, patients with Lenke 1A curves will be randomized to a high- or low-density screw cohort. The high-density pattern will be designated as ≥ 1.8 implants per level fused. The low density pattern will be ≤ 1.4 screws per level fused. At least 75% of the implants must be pedicle screws for both cohorts.
Minimum Number of Screws
ACTIVE COMPARATOROnce enrolled and consented, patients with Lenke 1A curves will be randomized to a high- or low-density screw cohort. The high-density pattern will be designated as ≥ 1.8 implants per level fused. The low density pattern will be ≤ 1.4 screws per level fused. At least 75% of the implants must be pedicle screws for both cohorts.
Interventions
The tools used for this arm of study are FDA approved with section 510 (k) K122433. These screws are regularly used in all procedures pertaining to Cobb angle correction surgeries outside of the context of this study.
The tools used for this arm of study are FDA approved with section 510 (k) K122433. These screws are regularly used in all procedures pertaining to Cobb angle correction surgeries outside of the context of this study.
Eligibility Criteria
You may qualify if:
- Patients aged ≥10 and ≤ 18 years
- Male or Female
- Diagnosis of idiopathic scoliosis for which surgery is recommended to prevent the curvature or to correct trunk disfigurement Lenke 1A curve pattern
- Curve cobb of 45° to 65°
- T5-T12 kyphosis measuring 0° to 40°
- Spina bifida Oculta is permitted
- Spondylolisthesis and Spondylolysis are permitted, as long as non- operative
You may not qualify if:
- Prior spinal surgery
- MRI abnormalities (including \>4mm of Syrinx and/or Chiari malformation)
- Neuromuscular or other serious co-morbidities
- Thoracogenic or cardiogenic scoliosis
- Associated syndrome or developmental delay
- Unable or unwilling to firmly commit to returning for required follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- Alfred I. duPont Hospital for Childrencollaborator
- Texas Scottish Rite Hospital for Childrencollaborator
- Johns Hopkins Universitycollaborator
- University of Rochestercollaborator
- Washington University School of Medicinecollaborator
- Children's Hospital Coloradocollaborator
- Mayo Cliniccollaborator
- University of Iowacollaborator
- Norton Leatherman Spine Centercollaborator
- Children's Hospital of Philadelphiacollaborator
- St. Justine's Hospitalcollaborator
Study Sites (14)
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Nemours/ Alfred I. duPont Hospital for Children
Wilmington, Delaware, 19803, United States
Children's Research Institute
Washington D.C., District of Columbia, 20010-2916, United States
University of Florida
Gainesville, Florida, 32611, United States
Emory University
Atlanta, Georgia, 30329, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Norton Leatherman Spine Center
Louisville, Kentucky, 40207, United States
Johns Hopkins University
Baltimore, Maryland, 21205, United States
University of Minnesota
Minneapolis, Minnesota, 55454, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
The Washington University in St. Louis
St Louis, Missouri, 63110, United States
University of Rochester
Rochester, New York, 14618, United States
Texas Scottish Rite Hospital for Children
Dallas, Texas, 75219, United States
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, H3T1C5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David W Polly, MD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2013
First Posted
February 15, 2013
Study Start
April 18, 2013
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
August 3, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share